Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation

European Journal of Haematology

Volumn 89, Issue 6, 2012, Pages 497-500

  Tamaki, Hiroya ^a   Fujioka, Tatsuya ^a   Ikegame, Kazuhiro ^a   Yoshihara, Satoshi ^a   Kaida, Katsuji ^a   Taniguchi, Kyoko ^a   Kato, Ruri ^a   Tokugawa, Taduko ^a   Nakata, Jun ^a   Inoue, Takayuki ^a   Yano, Aya ^a   Eguchi, Ryoji ^a   Okada, Masaya ^a   Maruya, Etsuko ^b   Saji, Hiroh ^c   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TERASAKI FOUNDATION LABORATORY   (United States)

^c Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

Author keywords

11q23 translocations; Copy number neutral loss of heterozygosity; Haploidentical transplantation; MLL AF6; Uniparental disomy

Indexed keywords

FLUDARABINE; LEUKOCYTE ANTIGEN; MELPHALAN; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; CANCER CELL; CASE REPORT; CHROMOSOME TRANSLOCATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENOTYPE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MISMATCH NEGATIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; RELAPSE; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADULT; BONE MARROW TRANSPLANTATION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; RECURRENCE; T-LYMPHOCYTES; TISSUE DONORS; TRANSLOCATION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84869877643     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12017     Document Type: Article

References (13)

1. Sprangers B, Van Wijmeersch B, Fevery S, Waer M, Billiau AD. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect. Nat Clin Pract Oncol 2007;4:404-14.
2. Ogawa H, Ikegame K, Kawakami M, et al. Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation. Transplantation 2004;78:488-9.
3. Hu YX, Cui Q, Liang B, Huang H. Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011;17:1099-111.
4. Vago L, Perna SK, Zanussi M, et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 2009;361:478-88.
5. Villalobos IB, Takahashi Y, Akatsuka Y, et al. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. Blood 2010;115:3158-61.
6. Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M, Inoko H. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005;57:717-29.
7. Ogawa H, Ikegame K, Kaida K, et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 2008;36:1-8.
8. Ogawa H, Ikegame K, Yoshihara S, et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006;12:1073-84.
9. Seliger B, Atkins D, Bock M, Ritz U, Ferrone S, Huber C, Storkel S. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Clin Cancer Res 2003;9:1721-7.
10. Baba T, Hanagiri T, Ichiki Y, Kuroda K, Shigematsu Y, Mizukami M, Sugaya M, Takenoyama M, Sugio K, Yasumoto K. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B. Cancer Sci 2007;98:1795-802.
11. Masuda K, Hiraki A, Fujii N, et al. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts. Cancer Sci 2007;98:102-8.
12. Demanet C, Mulder A, Deneys V, Worsham MJ, Maes P, Claas FH, Ferrone S. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood 2004;103:3122-30.
13. Eklund EA. Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators. Curr Opin Hematol 2010;17:75-8.